COPD trial uses mobile health to provide rehab at home

Wednesday, September 16, 2015

MINNEAPOLIS – The Minnesota HealthSolutions Corporation has tapped Novum, a consumer health engagement platform, as a partner on a mobile health clinical trial program designed to motivate and monitor people with COPD. Many of the millions of people affected with COPD are not able to participate in pulmonary rehab in a clinical setting and the program, delivered through the Novu platform, will enable them to complete home exercise more easily, according to a press release. “We believe that digital consumer tools can enable traditional protocols to work more efficiently in reaching patients, reducing hospital admissions and creating better outcomes,” said Ali Shirvani-Mahdavi, executive vice president of strategy and programs at Novu. In its next phase, the program will be evaluated in a controlled human study at the Mayo Clinic. Novu recently raised $20 million in funding from SSM Partners and Noro-Moseley Partners.


Is the Mayo Clinic looking for participants for the study?